Plasmacytic cutaneous pathology: A review.
amyloid
immunoglobulins
lymphoma
myeloma
plasma cell
Journal
Journal of cutaneous pathology
ISSN: 1600-0560
Titre abrégé: J Cutan Pathol
Pays: United States
ID NLM: 0425124
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
05
02
2019
revised:
02
05
2019
accepted:
13
05
2019
pubmed:
17
5
2019
medline:
17
1
2020
entrez:
17
5
2019
Statut:
ppublish
Résumé
We review the spectrum of cutaneous disorders associated with inflammatory and neoplastic plasmacytic pathology. Because plasma cells are derived from B-lymphocytes our overview includes discussion of certain lymphoplasmacytic proliferations. It is structured along histopathological lines, addressing conditions characterized by (a) cutaneous plasma cell infiltrates, (b) deposits of plasma cell products or their derivatives in the skin and (c) miscellaneous, poorly understood cutaneous complications of plasmacytic disorders. Lesions arising primarily in the skin and those due to cutaneous involvement by multisystem disorders are addressed. The range includes a spectrum of tumefactive and circulatory manifestations. We highlight key clinical and pathological features of the different conditions and outline recent advances in our understanding of these entities. By emphasizing the dermatopathological characteristics of this spectrum of disorders we hope to hone the diagnostic accuracy of practitioners in the field.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
698-708Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Alsaad KO, Ghazarian D. My approach to superficial inflammatory dermatoses: review. J Clin Pathol. 2005;58:1233-1241.
Hsiao P-F, Wu Y-H. Characterization of cutaneous plasmacytosis at different disease stages. Dermatology. 2016;232:738-747. https://doi.org/10.1159/000456073.
Nitta Y. Case of malignant lymphoma associated with primary systemic plasmacytosis with polyclonal hypergammaglobulinemia. Am J Dermatopathol. 1997;19(3):289-293.
Georgesen C, Kheterpal M, Pulitzer M. A rare case of cutaneous plasmacytosis in a Korean male. Case Rep Pathol. 2017;2017:6. https://doi.org/10.1155/2017/3032941.
Han XD, Lee SSJ, Tan SH, et al. Cutaneous plasmacytosis: a clinicopathologic study of a series of cases and their treatment outcomes. Am J Dermatopathol. 2018;40:36-42. https://doi.org/10.1097/DAD.0000000000000907.
Takeuchi M, Sato Y, Takata K, et al. Cutaneous multicentric Castleman's disease mimicking IgG4-related disease. Pathol Res Pract. 2012;208:746-749. https://doi.org/10.1016/j.prp.2012.09.006.
Muzes G, Sipos F, Csomor J, Sreter L. Multicentric Castleman's disease: a challenging diagnosis. Pathol Oncol Res. 2013;19:345-351. https://doi.org/10.1007/s12253-013-9619-z.
Perugino CA, Mattoo H, Mahajan VS, et al. IgG4-related disease: insights into human immunology and targeted therapies. Arthritis Rheumatol. 2017;69:1722-1732. https://doi.org/10.1002/art.40168.
Cesarino AM, Lonardi S, Facchetti F. Granuloma faciale: a cutaneous lesion sharing features with IgG4-associated sclerosing disease. Am J Surg Pathol. 2013;37(1):66-73.
Gilliam AC, Mullen RH, Oviedo G, et al. Isolated benign cutaneous plasmacytosis in children: two illustrative cases. Arch Dermatol. 2009;145:299-302.
Fried I, Wiesner T, Cerroni L. Pretibial lymphoplasmacytic plaque in children. Arch Dermatol. 2010;146:95-96. https://doi.org/10.1001/archdermatol.2009.341.
Fernandes-Flores A, Suarez Penaranda JM, De Toro G, et al. Expression of peripheral node addressins by plasmacytic plaque of children, APACHE, TRAPP and primary cutaneous angioplasmacellular hyperplasia. Appl Immunohistochem Mol Morphol. 2018;26(6):411-419.
Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105:3768-3785.
Isaacson PG, Chott A, Nakamura S, Muller-Hermelink HK, Harris NL, Swerdlow SH. Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma). In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: IARC Press; 2008:214-217.
Cerroni L. Cutaneous marginal zone lymphoma (cutaneous MALT-lymphoma) and variants. Skin Lymphoma: The Illustrated Guide. 4th ed. West Sussex, UK: Wiley Blackwell; 2014:201-219.
Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia. Arch Pathol Lab Med. 2013;137:580-585. https://doi.org/10.5858/arpa.2012-0034-RS.
Poulain S, Roumier C, Decambron A, et al. MYD88 L265P mutation in Waldenstrom macroglobulinemia. Blood. 2013;121(22):4504-4511.
Marchica V, Accardi F, Storti P, et al. Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin? Int J Hematol. 2017;105:104-108. https://doi.org/10.1007/s12185-016-2104-1.
Requena L, Kutzner H, Palmedo G, et al. Cutaneous involvement in multiple myeloma: a clinicopathologic, immunohistochemical, and cytogenetic study of 8 cases. Arch Dermatol. 2003;139:475-486. https://doi.org/10.1001/archderm.139.4.475.
Malysz J, Talamo G, Zhu J, et al. Cutaneous involvement in multiple myeloma (MM): a case series with clinicopathologic correlation. J Am Acad Dermatol. 2016;74:878-884.
Bhutani M, Shahid Z, Schnebelen A, Alapat D, Usmani SZ. Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders. Semin Oncol. 2016;43:395-400.
Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015;125:2323-2330. https://doi.org/10.1182/blood-2014-10-567479.
Edinget JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol. 2010;34:1830-1841. https://doi.org/10.1097/PAS.0b013e3181f72835.
Dammacco F, Sansonno D, Piccoli C, Tucci FA, Raconelli V. The cryoglobilins: an overview. Eur J Clin Invest. 2001;31(7):628-638.
Gammon B, Longmire M, DeClerck B. Intravascular crystal deposition: an early clue to the diagnosis of type 1 cryoglobulinemic vasculitis. Am J Dermatopathol. 2014;36:751-755. https://doi.org/10.1097/DAD.0b013e31829ff8d9.
Camp BJ, Magro CM. Cutaneous macroglobulinosis: a case series. J Cutan Pathol. 2012;39:962-970. https://doi.org/10.1111/j.1600-0560.2012.01983.x.
Alegria-Landa V, Cerroni L, Kutzner H, Requena L. Paraprotein deposits in the skin. J Am Acad Dermatol. 2017;77:1145-1158.
Shakeri A, Kaffenberger BH, Gru AA. Cutaneous macroglobulinosis as the initial presentation of Waldenstrom macroglobulinemia in a patient with a history of diffuse large B-cell lymphoma. J Cutan Pathol. 2018;45:962-964.
Pock L, Stuchlik D, Hercogova J. Crystal storing histiocytosis of the skin associated with multiple myeloma. Int J Dermatol. 2006;45:1408-1411. https://doi.org/10.1111/j.1365-4632.2006.02919.x.
Heathcote JG, Walsh NM, Sutton ED, Valenzuela AA. IgG4-related disease manifesting as sclerosing orbital inflammation and cutaneous pseudolymphoma with crystal-storing histiocytosis. Instructive case. Diagn Histopathol. 2013;19:147-150.
Li JJ, Henderson C. Cutaneous crystal storing histiocytosis: a report of two cases. J Cutan Pathol. 2015;42:136-143. https://doi.org/10.1111/cup.12413.
Arnold CA, Frankel WL, Guo L, et al. Crystal-storing histiocytosis in the stomach. A clue to subtle hematolymphoid malignancies. Am J Surg Pathol. 2018;42:1317-1324.
Merlini G, Stone MJ. Dangerous small B-cell clones. Review in translational hematology. Blood. 2006;108:2520-2530. https://doi.org/10.1182/blood-2006-03-001164.
Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387:2641-2654. https://doi.org/10.1016/S0140-6736(15)01274-X.
Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR III, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114:4957-4959. https://doi.org/10.1182/blood-2009-07-230722.
Walsh NM, Lano IM, Green P, et al. AL amyloidoma of the skin / subcutis. Cutaneous amyloidosis, plasma cell dyscrasia or a manifestation of primary cutaneous marginal zone lymphoma? Am J Surg Pathol. 2017;41:1069-1076.
Lynch PJ, Winkelmann RK. Generalized plane xanthoma and systemic disease. Arch Dermatol. 1966;93:639-646. https://doi.org/10.1001/archderm.1966.01600240005001.
Wilson DE, Flowers CM, Hershgold EJ, Eaton RP. Multiple myeloma, cryoglobulinemia and xanthomatosis: distinct clinical and biochemical syndromes in two patients. Am J Med. 1975;59:721-729. https://doi.org/10.1016/0002-9343(75)90233-8.
Coburn PR, Cream JJ, Johnson ML. Xanthomatosis and benign paraproteinemia. Br J Dermatol. 1983;109:100.
Groszek E, Abrams JJ, Grundy SM. Normolipidemic planar xanthomatosis associated with benign monoclonal gammopathy. Metabolism. 1981;30:927-935. https://doi.org/10.1016/0026-0495(81)90073-1.
Kovary PM, Vakilzadeh F, Macher E, Zaun H, Merk H, Goerz G. Monoclonal gammopathy in scleredema. Observations in three cases. Arch Dermatol. 1981;117:536-539. https://doi.org/10.1001/archderm.1981.01650090018016.
Ratip S, Akin H, Ozdemirli M, et al. Scleredema of Buschke associated with Waldenstrom's macroglobulinaemia. Br J Dermatol. 2000;143:450-452. https://doi.org/10.1046/j.1365-2133.2000.03683.x.
Beers WH, Ince A, Moore TL. Scleredema adultorum of Buschke: a case report and review of the literature. Semin Arthritis Rheum. 2006;35:355-359. https://doi.org/10.1016/j.semarthrit.2006.01.004.
Boin F, Hummers LK. Scleroderma-like fibrosing disorders. Rheum Dis Clin North Am. 2008;34:199-220. https://doi.org/10.1016/j.rdc.2007.11.001.
Cokonis Georgakis C-D, Falasca G, Georgakis A, Heymann WR. Scleromyxedema. Clin Dermatol. 2006;24:493-497. https://doi.org/10.1016/j.clindermatol.2006.07.011.
Fleming KE, Virmani D, Sutton E, et al. Scleromyxedema and the dermato-neuro syndrome: case report and review of the literature. J Cutan Pathol. 2012;39:508-517. https://doi.org/10.1111/j.1600-0560.2012.01882.x.
Wood AJ, Wagner VU, Abbott JJ, Gibson LE. Necrobiotic xanthogranuloma. A review of 17 cases with emphasis on clinical and pathologic correlation. Arch Dermatol. 2009;145:279-284. https://doi.org/10.1001/archdermatol.2008.583.
de Koning HD, Bodar EJ, van der Meer JWM, Simon A. Schnitzler syndrome: beyond the case reports: review and follow-up of 94 patients with an emphasis on prognosis and treatment. Semin Arthritis Rheum. 2007;37:137-148. https://doi.org/10.1016/j.semarthrit.2007.04.001.
Simon A, Asli B, Braun-Falco M, et al. Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy. 2013;68:562-568. https://doi.org/10.1111/all.12129.
Chan JK, Fletcher CD, Hicklin GA, Rosai J. Glomeruloid hemangioma. A distinctive cutaneous lesion of multicentric Castleman's disease associated with POEMS syndrome. Am J Surg Pathol. 1990;14:1036-1046.
Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: definitions and long-term outcome. Blood. 2003;101:2496-2506. https://doi.org/10.1182/blood-2002-07-2299.
Ordway S, Gilbert L, Wanko S. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation. BMJ Case Rep. 2018;2018. https://doi.org/10.1136/bcr-2017-223168.
Harati A, Brockmeyer NH, Altmeyer P, Kreuter A. Skin disorders in association with monoclonal gammopathies. Eur J Med Res. 2005;10:93-104.
Glavey SV, Leung N. Monoclonal gammopathy: the good, the bad and the ugly. Blood Rev. 2016;30:223-231.